4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-254038
Director sold 17,537 shares at an average $229.20 ($4,019,470)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Coleman Mark · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-29 | Sale : show line 1 in the form 10b5-1 | −6,000 | $233.46 | $1,400,760 | 41,140 | D |
| 2026-06-01 | Sale : show line 2 in the form 10b5-1 | −6,000 | $230.30 | $1,381,800 | 35,140 | D |
| 2026-06-02 | Sale : show line 3 in the form 10b5-1 | −5,537 | $223.39 | $1,236,910 | 29,603 | D |
| Open-market sales · 17,537 sh · avg $229.20 · $4,019,470 | ||||||
Loading xslF345X06/ownership.xml…